Xylazine Exposure and Addiction Treatment: A Growing Concern

Los Angeles, CA – March 17, 2026 – Muse Treatment Alcohol & Drug Rehab Los Angeles has released a new educational resource addressing the complexities of withdrawal treatment for xylazine exposure, often referred to as the “zombie drug.” This comes as xylazine’s presence in the illicit drug supply continues to rise, posing significant challenges for addiction treatment providers and public health officials.

Understanding Xylazine

Xylazine is a non-opioid sedative originally approved by the U.S. Food and Drug Administration for veterinary use. It is increasingly being detected in the illicit drug supply, frequently combined with fentanyl, according to the Centers for Disease Control and Prevention (CDC). The Drug Enforcement Administration (DEA) has reported a substantial increase in seizures of fentanyl mixed with xylazine across the United States.

The Challenges of Xylazine Exposure

Xylazine complicates overdose response because naloxone, a life-saving medication for opioid overdoses, does not reverse the sedative effects of xylazine. Exposure presents unique withdrawal and stabilization considerations, differing from traditional opioid withdrawal. Patients may experience profound sedation, hypotension, and skin ulcerations, particularly with prolonged exposure. These symptoms require specialized medical attention.

Muse Treatment’s Approach to Xylazine Withdrawal

Muse Treatment Alcohol & Drug Rehab Los Angeles emphasizes that detox services must account for polysubstance interactions, especially when opioids, stimulants, and sedatives are combined. Their approach includes:

• Careful Medical Monitoring: Continuous observation of vital signs and cardiovascular function.
• Symptom Stabilization: Managing the unique withdrawal symptoms associated with xylazine, including sedation and hypotension.
• Comprehensive Assessment: Evaluating for co-occurring opioid dependence, particularly when fentanyl is involved.
• Wound Care: Addressing skin ulcerations with appropriate medical interventions.

The Importance of Integrated Treatment

Beyond detox, Muse Treatment integrates structured drug rehab and alcohol rehab programs that incorporate behavioral therapies. Cognitive behavioral therapy (CBT), group counseling, and relapse prevention planning are key components of their treatment approach. The National Institutes of Health (NIH) has demonstrated that long-term engagement in structured treatment improves recovery outcomes.

Addressing Co-Occurring Mental Health Conditions

Muse Treatment recognizes the frequent intersection of substance use and mental health conditions. Integrated dual diagnosis treatment models address both substance use and co-occurring conditions like anxiety, depression, and trauma. This holistic approach aligns with national clinical guidelines.

Overdose Response and Community Awareness

The CDC continues to recommend naloxone availability in communities experiencing high rates of opioid involvement, even when xylazine is present, to reverse opioid effects. However, the sedative effects of xylazine necessitate additional medical evaluation. Muse Treatment’s resource aims to clarify these emerging substance-related risks and promote overdose preparedness.

Treatment Services Offered by Muse Treatment

Muse Treatment Alcohol & Drug Rehab Los Angeles provides a continuum of care including:

• Medically Supervised Detox Services
• Residential Treatment
• Outpatient Care
• Dual Diagnosis Support

Key Takeaways

• Xylazine is a dangerous sedative increasingly found in the illicit drug supply, often mixed with fentanyl.
• Naloxone does not reverse the effects of xylazine, complicating overdose response.
• Xylazine withdrawal presents unique challenges requiring specialized medical care.
• Integrated treatment addressing both substance use and mental health is crucial for successful recovery.

By providing educational resources and comprehensive treatment services, Muse Treatment Alcohol & Drug Rehab Los Angeles aims to address the growing public health crisis posed by xylazine exposure and contribute to safer communities in Los Angeles and beyond.

For more information about Muse Treatment, contact info@musetreatment.com or call (800) 426-1818.